Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
Diagn Cytopathol. 2020 Jun;48(6):581-585. doi: 10.1002/dc.24422. Epub 2020 Apr 9.
Papillary thyroid carcinoma (PTC) tall cell variant (TCV) with squamous dedifferentiation is a rare entity. We present a case of 90-year-old woman who initially had a 2.8 cm conventional PTC in right lobe of thyroid who, couple decades later, had metastatic dedifferentiated PTC to right neck lymph nodes level II and IV with tall cell features; to right level IV and V lymph nodes with tall cell and squamous components, which recently presented exclusively as squamous cell carcinoma (SCC) metastasizing to lung. The squamous component in the lymph node and SCC in the lung were both positive for squamous marker p63 and PTC markers TTF1, PAX-8 and BRAF V600E while negative for thyroglobulin and p16. The papillary component was positive for TTF-1, BRAF V600E and P63 (majority); negative for thyroglobulin and p16. Final diagnoses were rendered based on combination of cytological features and immunohistochemical profiles. This report highlights the utilization of current biomarkers to distinguish between metastatic dedifferentiated PTC with squamous features and primary lung SCC, as well as the importance of recognizing this rare entity.
甲状腺乳头状癌(PTC)高细胞变体(TCV)伴鳞状去分化是一种罕见的实体。我们报告了一例 90 岁女性的病例,她最初在甲状腺右叶有 2.8cm 的常规 PTC,二十年后,右侧颈部淋巴结 II 区和 IV 区有转移性去分化 PTC,具有高细胞特征;右侧 IV 区和 V 区有高细胞和鳞状成分的转移,最近仅表现为肺转移的鳞状细胞癌(SCC)。淋巴结中的鳞状成分和肺中的 SCC 均为鳞状标志物 p63 和 PTC 标志物 TTF1、PAX-8 和 BRAF V600E 阳性,而甲状腺球蛋白和 p16 阴性。乳头状成分 TTF-1、BRAF V600E 和 P63(大部分)阳性;甲状腺球蛋白和 p16 阴性。最终诊断是基于细胞学特征和免疫组化特征的组合。本报告强调了利用当前的生物标志物来区分具有鳞状特征的转移性去分化 PTC 和原发性肺 SCC,以及认识这种罕见实体的重要性。